TISSUE REGENERATION AT INDENT AND LG DENTAL

Therapy to stimulate healing in our patients

Nowadays, nobody finds strange how much technology and medicine have evolved. Currently, tissue bioengineering is a very helpful therapeutic tool for dentists and dental surgeons when treating their patients. In this case, we are making reference to growth factors, proteins present in the blood (plasma and platelets), which generate a series of phenomena that stimulate the proliferation and differentiation of cells in the formation of new blood vessels.  In addition, this produces the migration of beneficial cells to aid the process of repairing and healing the damaged area. The first growth factor was discovered by D. Rita Levi Montalcini in 1948, and the second one, by her colleague, Stanley Cohen, in 1952.  They both were awarded the Nobel Prize in Medicine in 1986.

There are numerous scientific papers that support the use of different platelet concentrates for the stimulation of healing.  In dentistry, we can speak of a new generation of these concentrates, called Platelet-Rich Fibrin (PRF). This is an autologous preparation obtained by the centrifugation of the patient’s own blood, non-toxic, chemical-free  and rich in platelets, leukocytes, growth factors and stem cells.  It is covered by a protein mesh called fibrin that functions as a dosage dispenser, as it controls the slow release of the preparation in the wounded area. It is important to emphasize that the presence of leukocytes in the fibrin mesh, as they regulate the inflammation process and protect patients from post-operative infections. All this guarantees a safe and fast recovery.

PRF are part of the therapeutic tools that Indent and LG Dental use and combine with other treatments to cure their patients.  In this way, PRF can be used for bone regeneration, soft tissue grafts and implants, etcetera, by stimulating the healing of those procedures and giving more safety and comfort to the patient.

The process to obtain PRF is pretty simple:

It only requires a sample of the patient’s blood, which is subjected to centrifugation in order to obtain the preparation rich in platelets and fibrin.  A resistant membrane is obtained from the preparation, with all the concentrated PRF ready to be placed on the surgical zone.

This has several advantages:

It is autologous: it is obtained from the patient’s own blood, so there is no risk of disease transmission or rejection.

It is completely harmless and does not contain any chemical additives.  It can be considered as an optimised natural blood clot.

It is simple and inexpensive, making it accessible to all patients.